February 26, 2018 / 9:21 PM / 9 months ago

BRIEF-Volitionrx Limited Announces Interim Results From 680-Subject Clinical Trial In Colorectal Cancer

Feb 26 (Reuters) - Volitionrx Ltd:

* VOLITIONRX LIMITED ANNOUNCES INTERIM RESULTS FROM 680-SUBJECT CLINICAL TRIAL IN COLORECTAL CANCER

* VOLITIONRX - ‍STUDY DEMONSTRATES HIGH DETECTION RATES OF STAGE I CANCER,PRE-CANCEROUS ADENOMAS IN COLORECTAL CANCER SCREENING TRIAL FOR NU.Q BLOOD TEST​

* VOLITIONRX LTD - ‍DATA IS EXPECTED FROM 680-SUBJECT CLINICAL TRIAL IN 2018​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below